Literature DB >> 17309910

One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction.

M Penicka1, O Lang, P Widimsky, P Kobylka, T Kozak, T Vanek, J Dvorak, J Tintera, J Bartunek.   

Abstract

OBJECTIVE: To investigate the kinetics of myocardial engraftment of bone marrow-derived mononuclear cells (BMNCs) after intracoronary injection using 99mTc-d,l-hexamethylpropylene amine oxime (99mTc-HMPAO) nuclear imaging in patients with acute and chronic anterior myocardial infarction.
DESIGN: Nuclear imaging-derived tracking of BMNCs at 2 and 20 h after injection in the left anterior descending (LAD) coronary artery.
SETTING: Academical cardiocentre. PATIENTS: Five patients with acute (mean (SD) age 58 (11) years; ejection fraction range 33-45%) and five patients with chronic (mean (SD) age 50 (6) years; ejection fraction range 28-34%) anterior myocardial infarction.
INTERVENTIONS: A total of 24.2 x 10(8)-57.0 x 10(8) BMNCs (20% labelled with 700-1000 MBq 99mTc-HMPAO) were injected in the LAD coronary artery.
RESULTS: At 2 h after BMNC injection, myocardial activity was observed in all patients with acute (range 1.31-5.10%) and in all but one patient with chronic infarction (range 1.10-3.0%). At 20 h, myocardial engraftment was noted only in three patients with acute myocardial infarction, whereas no myocardial activity was noted in any patient with chronic infarction.
CONCLUSIONS: Engraftment of BMNCs shows dynamic changes within the first 20 h after intracoronary injection. Persistent myocardial engraftment was noted only in a subset of patients with acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17309910      PMCID: PMC1994434          DOI: 10.1136/hrt.2006.091934

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  18 in total

Review 1.  Bone marrow homing: the players, the playfield, and their evolving roles.

Authors:  Thalia Papayannopoulou
Journal:  Curr Opin Hematol       Date:  2003-05       Impact factor: 3.284

2.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

3.  Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection.

Authors:  Didier Blocklet; Michel Toungouz; Guy Berkenboom; Micheline Lambermont; Philippe Unger; Nicolas Preumont; Eric Stoupel; Dominique Egrise; Jean-Paul Degaute; Michel Goldman; Serge Goldman
Journal:  Stem Cells       Date:  2005-10-13       Impact factor: 6.277

4.  Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.

Authors:  Catalin Toma; Mark F Pittenger; Kevin S Cahill; Barry J Byrne; Paul D Kessler
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

5.  Transcoronary implantation of bone marrow stromal cells ameliorates cardiac function after myocardial infarction.

Authors:  Takayuki Saito; Jin-Qiang Kuang; Charles C H Lin; Ray C-J Chiu
Journal:  J Thorac Cardiovasc Surg       Date:  2003-07       Impact factor: 5.209

6.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1.

Authors:  Daniel J Ceradini; Anita R Kulkarni; Matthew J Callaghan; Oren M Tepper; Nicholas Bastidas; Mark E Kleinman; Jennifer M Capla; Robert D Galiano; Jamie P Levine; Geoffrey C Gurtner
Journal:  Nat Med       Date:  2004-07-04       Impact factor: 53.440

7.  Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling.

Authors:  Alexandra Aicher; Winfried Brenner; Maaz Zuhayra; Cornel Badorff; Schirin Massoudi; Birgit Assmus; Thomas Eckey; Eberhard Henze; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2003-04-14       Impact factor: 29.690

8.  Clinical experience with 99mTc-hexamethylpropylene-amineoxime for labelling leucocytes and imaging inflammation.

Authors:  A M Peters; H J Danpure; S Osman; R J Hawker; B L Henderson; H J Hodgson; J D Kelly; R D Neirinckx; J P Lavender
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

9.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962

10.  Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution.

Authors:  Israel M Barbash; Pierre Chouraqui; Jack Baron; Micha S Feinberg; Sharon Etzion; Ariel Tessone; Liron Miller; Esther Guetta; Dov Zipori; Laurence H Kedes; Robert A Kloner; Jonathan Leor
Journal:  Circulation       Date:  2003-08-04       Impact factor: 29.690

View more
  25 in total

Review 1.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

2.  Repairing damaged myocardium: evaluating cells used for cardiac regeneration.

Authors:  Adam J T Schuldt; Michael R Rosen; Glenn R Gaudette; Ira S Cohen
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

Review 3.  Imaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions.

Authors:  Luka Lezaic; François Haddad; Bojan Vrtovec; Joseph C Wu
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Oct-Dec

4.  Multimodality molecular imaging in cardiac regenerative therapy.

Authors:  Davis Vo; Patricia K Nguyen
Journal:  J Nucl Cardiol       Date:  2017-02-09       Impact factor: 5.952

5.  Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting.

Authors:  Frauke Hausburg; Paula Müller; Natalia Voronina; Gustav Steinhoff; Robert David
Journal:  J Vis Exp       Date:  2018-06-18       Impact factor: 1.355

Review 6.  Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology.

Authors:  T Jadczyk; A Faulkner; P Madeddu
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

Review 7.  Imaging cardiac stem cell therapy: translations to human clinical studies.

Authors:  Wendy Y Zhang; Antje D Ebert; Jagat Narula; Joseph C Wu
Journal:  J Cardiovasc Transl Res       Date:  2011-05-03       Impact factor: 4.132

8.  Optimized delivery system achieves enhanced endomyocardial stem cell retention.

Authors:  Atta Behfar; Jean-Pierre Latere; Jozef Bartunek; Christian Homsy; Dorothee Daro; Ruben J Crespo-Diaz; Paul G Stalboerger; Valerie Steenwinckel; Aymeric Seron; Margaret M Redfield; Andre Terzic
Journal:  Circ Cardiovasc Interv       Date:  2013-12-10       Impact factor: 6.546

9.  Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.

Authors:  Virginie F Forest; Ashok M Tirouvanziam; Christian Perigaud; Sarah Fernandes; Marion S Fusellier; Jean-Claude Desfontis; Claire S Toquet; Marie-Françoise M Heymann; Dominique P Crochet; Patricia F Lemarchand
Journal:  Stem Cell Res Ther       Date:  2010-03-15       Impact factor: 6.832

10.  Bone marrow tinctures for cardiovascular disease: lost in translation.

Authors:  Jalees Rehman
Journal:  Circulation       Date:  2013-04-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.